Now, while the overall outcomes I think are known to the audience, the first question that I would like to address to you as a neurologist is how you see the results in terms of stroke prevention.

Thank you, Lauren.

So it's really a pleasure to be here and as a neurologist to have the opportunity to discuss those results and those trials.

And of course, as a neurologist, I'm very much focused on stroke outcomes because these are the outcomes that matter for me and for my colleagues.

And so I think it's an exciting time.

We see that there are two large randomized controlled trials coming out, giving a lot of evidence, actually.

and we see that overall the stroke rates in both trials were quite low which i think is a good sign because stroke rates are low and both trials reported ischemic stroke but also hemorrhagic stroke sometimes merging those different stroke types together which for a stroke neurologist is a bit complicated because these These events are not 100% comparable.

So which patient group might be very attractive for a percutaneous LA occlusion in your perspective as a stroke neurologist?